The overexpression of ERAP2 has been demonstrated to be correlated with the poorer clinicopathological characteristics, including cervical lymph node metastasis, advanced overall stage, positive perineural invasion, and deeper tumor depth (Table 2), indicating that elevated ERAP2 levels contributed to poorer prognosis of OSCC patients. The gene discussed is ERAP2; the disease is neoplasm.